This thread has been renamed and moved to a different location; here is the link: http://www.flutrackers.com/forum/sho...904#post541904
Since September 29, 2013, no influenza-associated pediatric deaths occurring during the 2013-14 influenza season have been reported. Since September 30, 2012, 169 influenza-associated pediatric deaths occurring during the 2012-13 influenza season have been reported.
Two influenza-associated pediatric deaths occurring during the 2012-13 influenza season have been reported from OH and NM during MMWR week 44.
Novel influenza A virus infections: none reported for this week
Vancomycin-intermediate Staphylococcus aureus: 0 this week, 157 cumulative for 2013, 134 in 2012, 82 in 2011, 91 in 2010, 78 in 2009, 63 in 2008
Vancomycin-resistant Staphylococcus aureus: 0 for this year, 2 in 2012, 0 in 2011, 2 in 2010, 0 in 2009, 1 in 2008
Difference between Vancomycin-Intermediate Staphylococcus aureus (VISA) and Vancomycin-Resistant Staphylococcus aureus (VRSA):
If large doses of vancomycin might still be able to kill the S. aureus, it is called Vancomycin-intermediate S. aureus (VISA). If no amount of vancomycin will kill the S. aureus, it is called Vancomycin-resistant S.aureus (VRSA).
Since September 29, 2013, no influenza-associated pediatric deaths occurring during the 2013-14 influenza season have been reported. Since September 30, 2012, 169 influenza-associated pediatric deaths occurring during the 2012-13 influenza season have been reported.
Two influenza-associated pediatric deaths occurring during the 2012-13 influenza season have been reported from OH and NM during MMWR week 44.
Novel influenza A virus infections: none reported for this week
Vancomycin-intermediate Staphylococcus aureus: 0 this week, 157 cumulative for 2013, 134 in 2012, 82 in 2011, 91 in 2010, 78 in 2009, 63 in 2008
Vancomycin-resistant Staphylococcus aureus: 0 for this year, 2 in 2012, 0 in 2011, 2 in 2010, 0 in 2009, 1 in 2008
Difference between Vancomycin-Intermediate Staphylococcus aureus (VISA) and Vancomycin-Resistant Staphylococcus aureus (VRSA):
If large doses of vancomycin might still be able to kill the S. aureus, it is called Vancomycin-intermediate S. aureus (VISA). If no amount of vancomycin will kill the S. aureus, it is called Vancomycin-resistant S.aureus (VRSA).
Comment